Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work best when placed in the right location using proper technique. Subcutaneous injection—delivering medication into the fatty tissue layer between skin and muscle—is the standard route for GLP-1 therapy. PlexusDx provides detailed guidance to help patients self-inject safely and effectively.

Approved Subcutaneous Injection Sites for Semaglutide

The abdomen, thigh, and upper arm are the three primary locations where semaglutide can be injected subcutaneously. Each site contains sufficient fatty tissue to accommodate the needle and allow medication to distribute properly into the subcutaneous space. Clinical guidelines and patient safety data support all three locations as equally effective for GLP-1 delivery.

The abdomen is often considered the most accessible site because patients can easily visualize the injection area and control needle depth. The thigh works well for individuals who prefer injecting while seated or standing, offering stability during the procedure. The upper arm, particularly the back of the arm between shoulder and elbow, provides another convenient option, though some patients benefit from having a partner assist with this location.

PlexusDx recommends choosing whichever site feels most comfortable and accessible for your lifestyle. Consistency with one primary location helps establish a routine, though rotating between sites prevents tissue damage and maintains injection quality over time.

How to Rotate Injection Sites to Prevent Skin Damage

Rotating your injection site with each weekly dose prevents lipodystrophy—the development of dents or thickened areas in subcutaneous tissue—which can occur with repeated injections in the same spot. A practical rotation pattern involves using different areas within the same body region for the first month, then switching to a different region entirely. For example, inject the abdomen for four weeks using different spots each time, then move to the thigh for the next four weeks.

Maintain at least one finger-width distance between injection sites to ensure adequate spacing and tissue recovery. This spacing rule applies whether you rotate within the same body region or switch between regions. Proper rotation not only protects skin integrity but may also optimize medication absorption, as scar tissue and lipodystrophic areas can affect how effectively semaglutide enters the bloodstream.

Many patients find it helpful to mark a calendar or use a simple diagram showing their rotation schedule. PlexusDx patients can reference their personalized treatment plan, which includes specific guidance on site rotation matched to their dosing schedule.

Proper Semaglutide Injection Technique and Safety

Before injecting, wash your hands with soap and water and allow the injection site to air dry completely. Remove the needle cover only immediately before injection to maintain sterility. Pinch the skin gently at the chosen site to elevate the subcutaneous tissue, creating a clear target for the needle, then insert the needle at a 90-degree angle with a quick, confident motion rather than slowly.

Inject the medication slowly and steadily, allowing the solution to distribute properly through the fatty tissue. After the plunger is fully depressed, wait five seconds before withdrawing the needle to ensure complete delivery. Release the pinched skin gently and apply light pressure with a clean cotton ball or gauze for a few seconds if needed, though bleeding is uncommon with subcutaneous injections.

Never reuse needles, and dispose of used needles in a puncture-resistant sharps container. Store semaglutide according to package directions—typically refrigerated until first use, then at room temperature for up to 30 days. If you experience persistent pain, severe bruising, or signs of infection at injection sites, contact your healthcare provider or PlexusDx support team immediately.

Minimizing Bruising and Discomfort With Semaglutide Injections

Bruising at injection sites typically results from minor blood vessel trauma and resolves within 7–14 days without treatment. To minimize bruising, avoid injecting into areas with visible veins or bruises, and do not massage the injection site aggressively after administration. Applying a cold compress for one minute before injection may reduce pain sensation, while a warm compress after injection can promote blood flow and reduce stiffness.

Needle anxiety is common, but research shows that proper technique and calm, controlled breathing significantly reduce pain perception during subcutaneous injections. Using a fresh, sharp needle—never a reused needle—makes injection less uncomfortable. PlexusDx patients receive detailed injection training during their initial consultation, including video demonstrations and a nurse hotline for technique questions.

Some patients experience mild soreness or tenderness at the injection site for a few hours after administration. This localized reaction typically subsides quickly and can be managed with over-the-counter pain relief if needed. However, persistent pain, swelling, or redness lasting more than a few days should be reported to your healthcare provider.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

Injecting in the same spot repeatedly increases the risk of lipodystrophy—dents or thickened areas in skin—and may reduce medication absorption. PlexusDx recommends rotating sites weekly within your chosen body region, moving to a new region every 4 weeks. Proper rotation protects skin health and maintains consistent medication effectiveness.

Which injection site delivers semaglutide fastest?

Absorption speed is similar across the abdomen, thigh, and upper arm because all three sites contain adequate subcutaneous tissue. Individual variation in fat distribution and blood flow may cause minor differences, but clinical studies show no clinically significant difference in efficacy between sites. Your choice should prioritize comfort and accessibility.

Does PlexusDx provide injection training with my semaglutide prescription?

Yes. PlexusDx includes comprehensive injection guidance with every semaglutide prescription, starting at $149/month. New patients receive detailed written instructions, video demonstrations, and access to a nurse hotline for technique questions. Your personalized treatment plan includes a site rotation schedule matched to your dosing frequency.

What if I develop severe bruising or swelling after a semaglutide injection?

Mild bruising is normal and typically resolves within 7–14 days. However, severe bruising, significant swelling, warmth, or signs of infection (redness, pus, fever) require immediate medical attention. Contact your PlexusDx provider or healthcare team right away if you experience any concerning symptoms beyond typical mild discomfort.

Can the Precision Peptide Genetic Test help predict my injection site response?

The Precision Peptide Genetic Test ($99 add-on after first month) identifies genetic variants in GLP-1 and peptide pathways that influence your individual response to semaglutide, but it does not predict injection site reactions. This test helps PlexusDx optimize your dose and compound selection based on your genetic predispositions for best outcomes with personalized GLP-1 therapy.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves